Work

Intravitreal antiglaucoma treatment: refractive changes and retinal effects in rats

Year: 2026
Type: article
Abstract: To evaluate the effect of two extended-release intravitreal (IV) hypopressure and neuroprotective treatments on refractive error and the neuroretina in rat eyes with chronic glaucoma. Cohort study. A total of 192 Long–Evans rat right eyes were analyzed: 42 healthy, 25 with glaucoma induced by episcleral vein sclerosis (G-evs), 60 G-evs treated with a single IV brimonidine–Laponite injection (G-evs–Brimonidine), 45 with glaucoma induced by anterior chamber microspheres (G-Ms), and 20 G-Ms treated with two IV latanoprost microsphere injections (G-Ms–Latanoprost). Assessments included intraocular pressure (IOP, rebound tonometry), retinal ganglion cell (RGC) function (electroretinography), diopter power, and neuroretinal structure (peripapillary retinal nerve fiber layer [pRNFL], RGC layer, and whole retina by optical coherence tomography) over 24 weeks. IOP, Latency and amplitude of electroretinography, diopters, thicknesses of the retinal layers. IV-treated glaucomatous eyes showed significantly lower IOP: G-evs–Brimonidine and G-Ms–Latanoprost vs. healthy eyes, and higher ERG b-wave amplitudes (both p < 0.001). All glaucomatous eyes exhibited dioptric power loss vs. healthy. G-evs–Brimonidine stabilized refraction and preserved RGC layer thickness (both p < 0.05). Conversely, G-Ms–Latanoprost caused greater myopization ( p = 0.011) but increased central retinal volume ( p < 0.001) and pRNFL thickness, exceeding even healthy eyes ( p = 0.001). Extended-release IV brimonidine and latanoprost lowered IOP and improved neuroretinal function and structure. A single IV brimonidine injection stabilized refraction and preserved RGC integrity, whereas repeated IV latanoprost injections induced myopization while enhancing central retinal and pRNFL thickness. These findings suggest that sustained-release IV therapy exerts both hypopressure and neuroprotective effects, while repeated injections may also modify ocular refractive status in glaucomatous eyes.
Language: English
Subfield: Ophthalmology
Field: Medicine
Open Access status: gold
Estimated APC paid: $2,690
OpenAlex ID: W7226034722
FWCI:
Cites: 12
Cited by:
Related to: 10